FDA Brief

Warning letters Drugs

FDA warning letter to

ProRx, LLC

Issued Mar 4, 2025Posted Mar 4, 2025Center for Drug Evaluation and Research (CDER)

Compounding Pharmacy/Adulterated Drug Products. We haven't summarized this letter yet. Read it on fda.gov.

ProRx, LLC's FDA history

  1. ProRx LLC

    ProRx LLC, an outsourcing facility, made sterile compounded drugs under insanitary conditions and without required 503B eligibility.

    High risk

Full company page